Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs
The capacity of platelets to generate thromboxane A2, reflected by measurement of serum thromboxane B2 (TxB2), greatly exceeds the systemic production of thromboxane in vivo. Th...